| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.0M | +0.0% |
| R&D Expense | $38.4M | +94.4% |
| SG&A Expense | $16.0M | +23.5% |
| Operating Income | -$54.5M | -77.1% |
| Net Income | -$45.6M | -63.5% |
| EPS (Basic) | -$1.45 | +45.5% |
| EPS (Diluted) | -$1.45 | +45.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $75.8M | +0.9% |
| Short-term Investments | $75.4M | +281.7% |
| Current Assets | $152.8M | +58.1% |
| Total Assets | $160.3M | +65.7% |
| Current Liabilities | $4.5M | -21.2% |
| Stockholders' Equity | $155.8M | +71.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$42.4M | -78.6% |
| Investing Cash Flow | -$61.7M | -590.3% |
| Financing Cash Flow | $104.8M | +21.6% |